Vaso-occlusive painful events in sickle cell disease: impact on child well-being. - Wikidata - awgldk - TriplyDB

Vaso-occlusive painful events in sickle cell disease: impact on child well-being.

Vaso-occlusive painful events in sickle cell disease: impact on child well-being.

http://www.wikidata.org/entity/Q35043620

about

Coping and coping assistance among children with sickle cell disease and their parents Hydroxyurea in children with sickle cell disease: practice patterns and barriers to utilization.Development and validation of the Youth Acute Pain Functional Ability Questionnaire (YAPFAQ).The impact of a multidisciplinary pain management model on sickle cell disease pain hospitalizations Evaluation and Treatment of Sickle Cell Pain in the Emergency Department: Paths to a Better Future Health related quality of life among adolescents with sickle cell disease in Saudi Arabia PedsQL™ sickle cell disease module: feasibility, reliability, and validity.Health-related quality of life in children with sickle cell disease using the child health questionnaire Saudi SCD patients' symptoms and quality of life relative to the number of ED visits.Responsiveness of the PedsQL to pain-related changes in health-related quality of life in pediatric sickle cell disease.Benchmarking pain outcomes for children with sickle cell disease hospitalized in a tertiary referral pediatric hospital Impact of hydroxyurea on clinical events in the BABY HUG trial.Health-related quality of life in adults with sickle cell disease (SCD): a report from the comprehensive sickle cell centers clinical trial consortium.Initial Evaluation of the Pediatric PROMIS® Health Domains in Children and Adolescents With Sickle Cell Disease Health-related quality of life in pediatric minor injury: reliability, validity, and responsiveness of the Pediatric Quality of Life Inventory in the emergency department.Mistrust of Pediatric Sickle Cell Disease Clinical Trials Research.Differences in health-related quality of life in children with sickle cell disease receiving hydroxyurea Validation of the sickle cell disease pain burden interview-youth.Responsiveness of PROMIS® Pediatric Measures to Hospitalizations for Sickle Pain and Subsequent Recovery.PedsQL™ Multidimensional Fatigue Scale in sickle cell disease: feasibility, reliability, and validity Health-related quality of life in sickle cell disease: past, present, and future.Psychosocial and pharmacological management of pain in pediatric sickle cell disease.Impact of emergency department care on outcomes of acute pain events in children with sickle cell disease.Substance P is increased in patients with sickle cell disease and associated with haemolysis and hydroxycarbamide use.Sickle cell disease: primum non nocere (first do no harm).Quality of life in patients with sickle cell disease.Using photovoice to explore the unique life perspectives of youth with sickle cell disease: a pilot study.HABIT, a Randomized Feasibility Trial to Increase Hydroxyurea Adherence, Suggests Improved Health-Related Quality of Life in Youths with Sickle Cell Disease.[Formula: see text]Executive functioning and health-related quality of life in pediatric sickle cell disease.Sickle cell disease: a natural model of acute and chronic pain.

P2860

Q33735014-B76796C4-313A-43A5-B1AB-14CB3614E2CB Q34026647-97C01EA0-6FDC-4585-972C-A6E9D5B0D6F2 Q34617278-F6551898-3644-43F8-8DF1-DF798F1E31B3 Q34752970-BBDBA2E9-FF72-462B-9677-43BC9F4C9A44 Q34795456-70BB14B5-6290-43E3-9448-7E1113DCE373 Q35444416-A3351074-A48A-485E-9DCE-B242D8D52E65 Q35545910-4C5F774A-9E79-4396-8B7F-3C0A52518064 Q35776449-8F38AF51-E81F-4AFE-8DE5-A4AF60192AA6 Q36108267-972D8C74-DA87-4699-AC68-D28E14DF763A Q36114349-E87EE1B1-90FB-4A87-867E-55097300CF80 Q36138562-E11D9B85-9609-4460-8E0A-10D3BFC7AC0E Q36425423-FBE4CD62-7E66-42EF-90B2-C3C64E31389B Q36560689-EC39985C-ADEC-4D1C-B214-97A9EF910AC5 Q36803332-972ECDD7-7592-49CD-BCAB-969F5A31DB17 Q37021414-7A070149-0A2B-4002-9717-C84C5282945E Q37028600-6FBE0BF9-4205-493E-82B5-46B15C8FF494 Q37059877-0A1550EC-BD1D-41BE-BFFC-6774844CA7DE Q37138239-923AEBD7-AF53-4E2F-AA6F-A84E4D370AFE Q37322373-8BFD7B0E-90EB-4E7B-A0FE-159221CFBB52 Q37359944-9CAFC65C-F6CE-49C2-8FE3-4DC8277241B4 Q38004362-8691B7C9-2CF7-4506-9643-2240133C7C86 Q38200831-52BAAAAA-24D8-487D-AA03-32F62FD4B3D4 Q39495873-CD2D7B68-6600-48CD-AF91-85005586AEBA Q41635275-3A602CE5-2E1D-4A8B-886F-F26764900FD1 Q42938341-E79BA414-5246-45B7-AE96-D6DF42D17287 Q45036919-7474A070-FDDF-4AB7-94E5-F03185666427 Q46411032-1F1C274C-E875-4997-81D6-E276CABF5A5B Q52639727-84F91FE9-7844-45C8-8445-E5311ECE4536 Q52859053-EBF25AA5-FFCD-4450-BC2F-C8E873DA2DAE Q55053106-814D93ED-5F98-4F2B-93B7-9BC3CB75241C

P2860

Vaso-occlusive painful events in sickle cell disease: impact on child well-being.

http://www.wikidata.org/entity/Q35043620

description

2010 nî lūn-bûn

@nan

2010 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Vaso-occlusive painful events in sickle cell disease: impact on child well-being.

@en

type

label

Vaso-occlusive painful events in sickle cell disease: impact on child well-being.

@en

prefLabel

Vaso-occlusive painful events in sickle cell disease: impact on child well-being.

@en

P1433

Q35043620-9157071D-D8D5-47CD-AB56-94E2AB5A7CE8

P1476

Q35043620-8BF0AEBB-EC31-4815-AC60-A96CC2383AF5

P2093

Q35043620-08238FC7-BAB2-4C06-9773-9034610FCE08

Q35043620-2EE2872B-0952-4779-95FF-77FCC2E1C88D

Q35043620-6564464B-FB71-4F04-AD53-16787C4BEA76

Q35043620-E2CF2FE2-F74E-447F-80F1-A68C51ADBD3E

P2860

Q35043620-08D3CB97-5FE9-4A3D-82D7-5CF4BEBDCB16

Q35043620-2248C1C8-FD99-45C4-911A-B0105A08E704

Q35043620-279FD638-356F-45A0-88AB-FCD1EBC23233

Q35043620-2C957E5B-FC53-4427-8986-02B39C603619

Q35043620-2EB3BF37-B4CD-4280-BB94-4FC78899CE1F

Q35043620-370AEC35-E44D-457C-8043-0C0AFA7A2B68

Q35043620-3C28A14F-5254-4B85-B2E9-B1114848C333

Q35043620-5053CCC5-AEFF-4672-A53B-027A86E24910

Q35043620-5A39AB35-C664-4491-B7B7-DEE0F8786D7A

Q35043620-5D1BAD5C-B59E-4A40-9D05-8DF0BEC71014

P304

Q35043620-BAF970B6-BD93-41AB-A5B9-1180A9E21BD1

P31

Q35043620-C7165835-F88C-489A-AF00-5B6AC842BF6B

P356

Q35043620-7FAA2C15-966B-4900-9230-2863CE270286

P433

Q35043620-B6020205-D732-4A0D-94AC-BB1F5721AEFF

P478

Q35043620-BC889C47-C36B-424C-B64D-6CF8B3829331

P577

Q35043620-39DFE994-8D82-45F7-B001-564127604152

P5875

Q35043620-59B08B1C-70C3-4D85-AB92-3DB2F25896CB

P698

Q35043620-33217044-C83C-42F1-AA0D-709B53C27938

P921

Q35043620-DF7A324D-BFD5-4D81-9E70-0904583A697D

P932

Q35043620-FDFB3DAB-C9C2-42EC-8274-DF9C18AB4519

P356

P1433

Pediatric Blood & Cancer

P1476

Vaso-occlusive painful events in sickle cell disease: impact on child well-being.

@en

P2093

Amanda M Brandow

http://www.w3.org/2001/XMLSchema#string

David C Brousseau

http://www.w3.org/2001/XMLSchema#string

Julie A Panepinto

http://www.w3.org/2001/XMLSchema#string

Nicholas M Pajewski

http://www.w3.org/2001/XMLSchema#string

P2860

Can parents rate their child's health-related quality of life? Results of a systematic review.

Parental report of health-related quality of life in children with sickle cell disease.

Factors influencing agreement between child self-report and parent proxy-reports on the Pediatric Quality of Life Inventory 4.0 (PedsQL) generic core scales.

How young can children reliably and validly self-report their health-related quality of life?: an analysis of 8,591 children across age subgroups with the PedsQL 4.0 Generic Core Scales.

EuroQol (EQ-5D) measure of quality of life predicts mortality, emergency department utilization, and hospital discharge rates in HIV-infected adults under care

Is treatment adherence associated with better quality of life in children with sickle cell disease?

Pediatric health-related quality of life questionnaires in clinical trials.

The performance of the PedsQL generic core scales in children with sickle cell disease

Effects on cancer patients' health-related quality of life after the start of morphine therapy.

Comparison between celiac plexus block and morphine treatment on quality of life in patients with pancreatic cancer pain.

P304

92-97

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/PBC.22222

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

54

http://www.w3.org/2001/XMLSchema#string

P577

2010-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

26715544

http://www.w3.org/2001/XMLSchema#string

P698

19653296

http://www.w3.org/2001/XMLSchema#string

P921

sickle-cell disease

P932

3114448

http://www.w3.org/2001/XMLSchema#string